Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

March 01, 1988; Volume 16,Issue 2
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Atteba, S

    1. You have access
      Pre- and postweaning development of drug-metabolizing enzyme activities in small intestine and liver of rats.
      I de Waziers, M Boisset and S Atteba
      Drug Metabolism and Disposition March 1988, 16 (2) 310-315;

B

  1. Baker, M T

    1. You have access
      Metabolic activation of the halothane metabolite, [14C]2-chloro-1,1-difluoroethene, in hepatic microsomes.
      M T Baker and J N Bates
      Drug Metabolism and Disposition March 1988, 16 (2) 169-172;
  2. Bates, J N

    1. You have access
      Metabolic activation of the halothane metabolite, [14C]2-chloro-1,1-difluoroethene, in hepatic microsomes.
      M T Baker and J N Bates
      Drug Metabolism and Disposition March 1988, 16 (2) 169-172;
  3. Baughman, R A

    1. You have access
      Pharmacokinetics and tissue distribution of recombinant human tumor necrosis factor-alpha in mice.
      B L Ferraiolo, J A Moore, D Crase, P Gribling, H Wilking and R A Baughman
      Drug Metabolism and Disposition March 1988, 16 (2) 270-275;
  4. Beitner, D B

    1. You have access
      Regiochemistry and substrate stereoselectivity of O-demethylation of verapamil in the presence of the microsomal fraction from rat and human liver.
      W L Nelson, L D Olsen, D B Beitner and R J Pallow
      Drug Metabolism and Disposition March 1988, 16 (2) 184-188;
  5. Benet, L Z

    1. You have access
      Effect of pH on acyl migration and hydrolysis of tolmetin glucuronide.
      M L Hyneck, A Munafo and L Z Benet
      Drug Metabolism and Disposition March 1988, 16 (2) 322-324;
  6. Bertault-Peres, P

    1. You have access
      Metabolism of cyclosporin A. III. Interaction of the macrolide antibiotic, erythromycin, using rabbit hepatocytes and microsomal fractions.
      I Fabre, G Fabre, P Maurel, P Bertault-Peres and J P Cano
      Drug Metabolism and Disposition March 1988, 16 (2) 296-301;
  7. Boisset, M

    1. You have access
      Pre- and postweaning development of drug-metabolizing enzyme activities in small intestine and liver of rats.
      I de Waziers, M Boisset and S Atteba
      Drug Metabolism and Disposition March 1988, 16 (2) 310-315;
  8. Boyle, K E

    1. You have access
      Dose-dependent pharmacokinetics of recombinant tissue-type plasminogen activator in anesthetized dogs following intravenous infusion.
      K L Fong, C S Crysler, B A Mico, K E Boyle, G A Kopia, L Kopaciewicz and R K Lynn
      Drug Metabolism and Disposition March 1988, 16 (2) 201-206;
  9. Braham, Y

    1. You have access
      The rat biliary and urinary metabolism of the N6-methylated derivative of elliptinium acetate, and antitumor agent.
      Y Braham, G Meunier and B Meunier
      Drug Metabolism and Disposition March 1988, 16 (2) 316-321;
  10. Buben, J A

    1. You have access
      In vitro metabolism and covalent binding among ortho-substituted bromobenzenes of varying hepatotoxicity.
      P E Weller, N Narasimhan, J A Buben and R P Hanzlik
      Drug Metabolism and Disposition March 1988, 16 (2) 232-237;

C

  1. Caldwell, J

    1. You have access
      The metabolism and disposition of fenofibrate in rat, guinea pig, and dog.
      A Weil, J Caldwell and M Strolin-Benedetti
      Drug Metabolism and Disposition March 1988, 16 (2) 302-309;
  2. Cano, J P

    1. You have access
      Metabolism of cyclosporin A. III. Interaction of the macrolide antibiotic, erythromycin, using rabbit hepatocytes and microsomal fractions.
      I Fabre, G Fabre, P Maurel, P Bertault-Peres and J P Cano
      Drug Metabolism and Disposition March 1988, 16 (2) 296-301;
  3. Castagnoli, N

    1. You have access
      Quantitative analysis of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolism in isolated rat hepatocytes.
      D Di Monte, T Shinka, M S Sandy, N Castagnoli and M T Smith
      Drug Metabolism and Disposition March 1988, 16 (2) 250-255;
  4. Chan, T M

    1. You have access
      Identification of two metabolites of a penem (Sch 34343) in human urine.
      H Kim, B Pramanik, A Lapiguera, T M Chan, V M Girijavallabhan, S Symchowicz and C Lin
      Drug Metabolism and Disposition March 1988, 16 (2) 325-327;
  5. Coon, M J

    1. You have access
      Cytochrome P-450-dependent formation of ethylene from N-nitrosoethylamines.
      X X Ding and M J Coon
      Drug Metabolism and Disposition March 1988, 16 (2) 265-269;
  6. Crase, D

    1. You have access
      Pharmacokinetics and tissue distribution of recombinant human tumor necrosis factor-alpha in mice.
      B L Ferraiolo, J A Moore, D Crase, P Gribling, H Wilking and R A Baughman
      Drug Metabolism and Disposition March 1988, 16 (2) 270-275;
  7. Crysler, C S

    1. You have access
      Dose-dependent pharmacokinetics of recombinant tissue-type plasminogen activator in anesthetized dogs following intravenous infusion.
      K L Fong, C S Crysler, B A Mico, K E Boyle, G A Kopia, L Kopaciewicz and R K Lynn
      Drug Metabolism and Disposition March 1988, 16 (2) 201-206;

D

  1. D'Souza, M J

    1. You have access
      Cyclosporine-phenytoin interaction.
      M J D'Souza, S H Pollock and H M Solomon
      Drug Metabolism and Disposition March 1988, 16 (2) 256-258;
  2. Dain, J G

    1. You have access
      Effect of diet and gavage on the absorption and metabolism of fluperlapine in the rat.
      J G Dain and J M Jaffe
      Drug Metabolism and Disposition March 1988, 16 (2) 238-242;
  3. de Waziers, I

    1. You have access
      Pre- and postweaning development of drug-metabolizing enzyme activities in small intestine and liver of rats.
      I de Waziers, M Boisset and S Atteba
      Drug Metabolism and Disposition March 1988, 16 (2) 310-315;
  4. Diamond, G L

    1. You have access
      In vivo renal tubular secretion and metabolism of the disulfide of 2,3-dimercaptopropane-1-sulfonate.
      J R Stewart and G L Diamond
      Drug Metabolism and Disposition March 1988, 16 (2) 189-195;
  5. Digenis, G A

    1. You have access
      Disposition and metabolism of double-labeled [3H and 14C] N-methyl-2-pyrrolidinone in the rat.
      D A Wells and G A Digenis
      Drug Metabolism and Disposition March 1988, 16 (2) 243-249;
  6. Di Monte, D

    1. You have access
      Quantitative analysis of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolism in isolated rat hepatocytes.
      D Di Monte, T Shinka, M S Sandy, N Castagnoli and M T Smith
      Drug Metabolism and Disposition March 1988, 16 (2) 250-255;
  7. Ding, X X

    1. You have access
      Cytochrome P-450-dependent formation of ethylene from N-nitrosoethylamines.
      X X Ding and M J Coon
      Drug Metabolism and Disposition March 1988, 16 (2) 265-269;

F

  1. Fabre, G

    1. You have access
      Metabolism of cyclosporin A. III. Interaction of the macrolide antibiotic, erythromycin, using rabbit hepatocytes and microsomal fractions.
      I Fabre, G Fabre, P Maurel, P Bertault-Peres and J P Cano
      Drug Metabolism and Disposition March 1988, 16 (2) 296-301;
  2. Fabre, I

    1. You have access
      Metabolism of cyclosporin A. III. Interaction of the macrolide antibiotic, erythromycin, using rabbit hepatocytes and microsomal fractions.
      I Fabre, G Fabre, P Maurel, P Bertault-Peres and J P Cano
      Drug Metabolism and Disposition March 1988, 16 (2) 296-301;
  3. Ferraiolo, B L

    1. You have access
      Pharmacokinetics and tissue distribution of recombinant human tumor necrosis factor-alpha in mice.
      B L Ferraiolo, J A Moore, D Crase, P Gribling, H Wilking and R A Baughman
      Drug Metabolism and Disposition March 1988, 16 (2) 270-275;
  4. Fong, K L

    1. You have access
      Dose-dependent pharmacokinetics of recombinant tissue-type plasminogen activator in anesthetized dogs following intravenous infusion.
      K L Fong, C S Crysler, B A Mico, K E Boyle, G A Kopia, L Kopaciewicz and R K Lynn
      Drug Metabolism and Disposition March 1988, 16 (2) 201-206;
  5. Franklin, M R

    1. You have access
      N-benzylimidazole, a high magnitude inducer of rat hepatic cytochrome P-450 exhibiting both polycyclic aromatic hydrocarbon- and phenobarbital-type induction of phase I and phase II drug-metabolizing enzymes.
      D I Papac and M R Franklin
      Drug Metabolism and Disposition March 1988, 16 (2) 259-264;
  6. Frey, B M

    1. You have access
      Marked interspecies differences between humans and pigs in cyclosporine and prednisolone disposition.
      B M Frey, M Sieber, D Mettler, H Gänger and F J Frey
      Drug Metabolism and Disposition March 1988, 16 (2) 285-289;
  7. Frey, F J

    1. You have access
      Marked interspecies differences between humans and pigs in cyclosporine and prednisolone disposition.
      B M Frey, M Sieber, D Mettler, H Gänger and F J Frey
      Drug Metabolism and Disposition March 1988, 16 (2) 285-289;

G

  1. Gänger, H

    1. You have access
      Marked interspecies differences between humans and pigs in cyclosporine and prednisolone disposition.
      B M Frey, M Sieber, D Mettler, H Gänger and F J Frey
      Drug Metabolism and Disposition March 1988, 16 (2) 285-289;
  2. Garnes, D

    1. You have access
      Relationship between the pharmacokinetic and pharmacodynamic profile of nilvadipine in the dog.
      W H Wu, B M Henderson, R Lanc, D Garnes, A Yacobi and B M Silber
      Drug Metabolism and Disposition March 1988, 16 (2) 222-227;
  3. Giacomini, K M

    1. You have access
      Inhibition of cimetidine transport by creatinine in luminal membrane vesicles prepared from rabbit kidney.
      L G Gisclon and K M Giacomini
      Drug Metabolism and Disposition March 1988, 16 (2) 331-332;
  4. Girijavallabhan, V M

    1. You have access
      Identification of two metabolites of a penem (Sch 34343) in human urine.
      H Kim, B Pramanik, A Lapiguera, T M Chan, V M Girijavallabhan, S Symchowicz and C Lin
      Drug Metabolism and Disposition March 1988, 16 (2) 325-327;
  5. Gisclon, L G

    1. You have access
      Inhibition of cimetidine transport by creatinine in luminal membrane vesicles prepared from rabbit kidney.
      L G Gisclon and K M Giacomini
      Drug Metabolism and Disposition March 1988, 16 (2) 331-332;
  6. Glass, S J

    1. You have access
      Metabolism of 7-ethoxyresorufin by phenobarbital or Aroclor 1254 pretreated mice.
      S J Glass and R B van Lier
      Drug Metabolism and Disposition March 1988, 16 (2) 333-334;
  7. Gribling, P

    1. You have access
      Pharmacokinetics and tissue distribution of recombinant human tumor necrosis factor-alpha in mice.
      B L Ferraiolo, J A Moore, D Crase, P Gribling, H Wilking and R A Baughman
      Drug Metabolism and Disposition March 1988, 16 (2) 270-275;
  8. Gustavson, L M

    1. You have access
      Regioisomeric products of propranolol metabolism. The monomethyl ethers of 3,4-dihydroxypropranolol and of 3,4-dihydroxypropranolol glycol.
      L M Gustavson and W L Nelson
      Drug Metabolism and Disposition March 1988, 16 (2) 217-221;

H

  1. Hall, I H

    1. You have access
      The disposition of the hypolipidemic agent, o-(N-phthalimido)acetophenone, in Sprague-Dawley rats.
      I H Hall, D J Reynolds, S D Wyrick, J H Maguire and R P Shrewsbury
      Drug Metabolism and Disposition March 1988, 16 (2) 196-200;
  2. Hanano, M

    1. You have access
      Effect of serum from renal failure and cirrhotic patients on the blood-brain barrier permeability to DL-propranolol in rats.
      T H Lin, Y Sugiyama, Y Sawada, S Kawasaki, T Iga and M Hanano
      Drug Metabolism and Disposition March 1988, 16 (2) 290-295;
    2. You have access
      Efflux of cimetidine from the rat cerebrospinal fluid.
      H Suzuki, Y Sawada, Y Sugiyama, T Iga and M Hanano
      Drug Metabolism and Disposition March 1988, 16 (2) 328-330;
  3. Hanzlik, R P

    1. You have access
      In vitro metabolism and covalent binding among ortho-substituted bromobenzenes of varying hepatotoxicity.
      P E Weller, N Narasimhan, J A Buben and R P Hanzlik
      Drug Metabolism and Disposition March 1988, 16 (2) 232-237;
  4. Henderson, B M

    1. You have access
      Relationship between the pharmacokinetic and pharmacodynamic profile of nilvadipine in the dog.
      W H Wu, B M Henderson, R Lanc, D Garnes, A Yacobi and B M Silber
      Drug Metabolism and Disposition March 1988, 16 (2) 222-227;
  5. Hyneck, M L

    1. You have access
      Effect of pH on acyl migration and hydrolysis of tolmetin glucuronide.
      M L Hyneck, A Munafo and L Z Benet
      Drug Metabolism and Disposition March 1988, 16 (2) 322-324;

I

  1. Iga, T

    1. You have access
      Effect of serum from renal failure and cirrhotic patients on the blood-brain barrier permeability to DL-propranolol in rats.
      T H Lin, Y Sugiyama, Y Sawada, S Kawasaki, T Iga and M Hanano
      Drug Metabolism and Disposition March 1988, 16 (2) 290-295;
    2. You have access
      Efflux of cimetidine from the rat cerebrospinal fluid.
      H Suzuki, Y Sawada, Y Sugiyama, T Iga and M Hanano
      Drug Metabolism and Disposition March 1988, 16 (2) 328-330;

J

  1. Jaffe, J M

    1. You have access
      Effect of diet and gavage on the absorption and metabolism of fluperlapine in the rat.
      J G Dain and J M Jaffe
      Drug Metabolism and Disposition March 1988, 16 (2) 238-242;

K

  1. Kannan, R

    1. You have access
      Dose-dependent tissue uptake of flecainide during chronic administration in rabbits.
      R Kannan and A Matin-Asgari
      Drug Metabolism and Disposition March 1988, 16 (2) 228-231;
  2. Kawasaki, S

    1. You have access
      Effect of serum from renal failure and cirrhotic patients on the blood-brain barrier permeability to DL-propranolol in rats.
      T H Lin, Y Sugiyama, Y Sawada, S Kawasaki, T Iga and M Hanano
      Drug Metabolism and Disposition March 1988, 16 (2) 290-295;
  3. Kim, H

    1. You have access
      Identification of two metabolites of a penem (Sch 34343) in human urine.
      H Kim, B Pramanik, A Lapiguera, T M Chan, V M Girijavallabhan, S Symchowicz and C Lin
      Drug Metabolism and Disposition March 1988, 16 (2) 325-327;
  4. Kopaciewicz, L

    1. You have access
      Dose-dependent pharmacokinetics of recombinant tissue-type plasminogen activator in anesthetized dogs following intravenous infusion.
      K L Fong, C S Crysler, B A Mico, K E Boyle, G A Kopia, L Kopaciewicz and R K Lynn
      Drug Metabolism and Disposition March 1988, 16 (2) 201-206;
  5. Kopia, G A

    1. You have access
      Dose-dependent pharmacokinetics of recombinant tissue-type plasminogen activator in anesthetized dogs following intravenous infusion.
      K L Fong, C S Crysler, B A Mico, K E Boyle, G A Kopia, L Kopaciewicz and R K Lynn
      Drug Metabolism and Disposition March 1988, 16 (2) 201-206;

L

  1. Lanc, R

    1. You have access
      Relationship between the pharmacokinetic and pharmacodynamic profile of nilvadipine in the dog.
      W H Wu, B M Henderson, R Lanc, D Garnes, A Yacobi and B M Silber
      Drug Metabolism and Disposition March 1988, 16 (2) 222-227;
  2. Lapiguera, A

    1. You have access
      Identification of two metabolites of a penem (Sch 34343) in human urine.
      H Kim, B Pramanik, A Lapiguera, T M Chan, V M Girijavallabhan, S Symchowicz and C Lin
      Drug Metabolism and Disposition March 1988, 16 (2) 325-327;
  3. Lin, C

    1. You have access
      Identification of two metabolites of a penem (Sch 34343) in human urine.
      H Kim, B Pramanik, A Lapiguera, T M Chan, V M Girijavallabhan, S Symchowicz and C Lin
      Drug Metabolism and Disposition March 1988, 16 (2) 325-327;
  4. Lin, T H

    1. You have access
      Effect of serum from renal failure and cirrhotic patients on the blood-brain barrier permeability to DL-propranolol in rats.
      T H Lin, Y Sugiyama, Y Sawada, S Kawasaki, T Iga and M Hanano
      Drug Metabolism and Disposition March 1988, 16 (2) 290-295;
  5. Lynn, R K

    1. You have access
      Dose-dependent pharmacokinetics of recombinant tissue-type plasminogen activator in anesthetized dogs following intravenous infusion.
      K L Fong, C S Crysler, B A Mico, K E Boyle, G A Kopia, L Kopaciewicz and R K Lynn
      Drug Metabolism and Disposition March 1988, 16 (2) 201-206;

M

  1. Maguire, J H

    1. You have access
      The disposition of the hypolipidemic agent, o-(N-phthalimido)acetophenone, in Sprague-Dawley rats.
      I H Hall, D J Reynolds, S D Wyrick, J H Maguire and R P Shrewsbury
      Drug Metabolism and Disposition March 1988, 16 (2) 196-200;
  2. Matin-Asgari, A

    1. You have access
      Dose-dependent tissue uptake of flecainide during chronic administration in rabbits.
      R Kannan and A Matin-Asgari
      Drug Metabolism and Disposition March 1988, 16 (2) 228-231;
  3. Maurel, P

    1. You have access
      Metabolism of cyclosporin A. III. Interaction of the macrolide antibiotic, erythromycin, using rabbit hepatocytes and microsomal fractions.
      I Fabre, G Fabre, P Maurel, P Bertault-Peres and J P Cano
      Drug Metabolism and Disposition March 1988, 16 (2) 296-301;
  4. Mettler, D

    1. You have access
      Marked interspecies differences between humans and pigs in cyclosporine and prednisolone disposition.
      B M Frey, M Sieber, D Mettler, H Gänger and F J Frey
      Drug Metabolism and Disposition March 1988, 16 (2) 285-289;
  5. Meunier, B

    1. You have access
      The rat biliary and urinary metabolism of the N6-methylated derivative of elliptinium acetate, and antitumor agent.
      Y Braham, G Meunier and B Meunier
      Drug Metabolism and Disposition March 1988, 16 (2) 316-321;
  6. Meunier, G

    1. You have access
      The rat biliary and urinary metabolism of the N6-methylated derivative of elliptinium acetate, and antitumor agent.
      Y Braham, G Meunier and B Meunier
      Drug Metabolism and Disposition March 1988, 16 (2) 316-321;
  7. Mico, B A

    1. You have access
      Dose-dependent pharmacokinetics of recombinant tissue-type plasminogen activator in anesthetized dogs following intravenous infusion.
      K L Fong, C S Crysler, B A Mico, K E Boyle, G A Kopia, L Kopaciewicz and R K Lynn
      Drug Metabolism and Disposition March 1988, 16 (2) 201-206;
  8. Moore, J A

    1. You have access
      Pharmacokinetics and tissue distribution of recombinant human tumor necrosis factor-alpha in mice.
      B L Ferraiolo, J A Moore, D Crase, P Gribling, H Wilking and R A Baughman
      Drug Metabolism and Disposition March 1988, 16 (2) 270-275;
  9. Munafo, A

    1. You have access
      Effect of pH on acyl migration and hydrolysis of tolmetin glucuronide.
      M L Hyneck, A Munafo and L Z Benet
      Drug Metabolism and Disposition March 1988, 16 (2) 322-324;

N

  1. Narasimhan, N

    1. You have access
      In vitro metabolism and covalent binding among ortho-substituted bromobenzenes of varying hepatotoxicity.
      P E Weller, N Narasimhan, J A Buben and R P Hanzlik
      Drug Metabolism and Disposition March 1988, 16 (2) 232-237;
  2. Nelson, W L

    1. You have access
      Regiochemistry and substrate stereoselectivity of O-demethylation of verapamil in the presence of the microsomal fraction from rat and human liver.
      W L Nelson, L D Olsen, D B Beitner and R J Pallow
      Drug Metabolism and Disposition March 1988, 16 (2) 184-188;
    2. You have access
      Regioisomeric aromatic dihydroxylation of propranolol. Use of monohydroxylated intermediates for structural assignments of the metabolites formed in vitro.
      R E Talaat and W L Nelson
      Drug Metabolism and Disposition March 1988, 16 (2) 207-211;
    3. You have access
      Regioisomeric aromatic dihydroxylation of propranolol. Synthesis and identification of 4,6- and 4,8-dihydroxypropranolol as metabolites in the rat and in man.
      R E Talaat and W L Nelson
      Drug Metabolism and Disposition March 1988, 16 (2) 212-216;
    4. You have access
      Regioisomeric products of propranolol metabolism. The monomethyl ethers of 3,4-dihydroxypropranolol and of 3,4-dihydroxypropranolol glycol.
      L M Gustavson and W L Nelson
      Drug Metabolism and Disposition March 1988, 16 (2) 217-221;
  3. Neumann, H G

    1. You have access
      Modulation of trans-4-acetylaminostilbene metabolism in the rat by methylcholanthrene and phenobarbital and its relevance for acute toxicity.
      A Pfeifer and H G Neumann
      Drug Metabolism and Disposition March 1988, 16 (2) 276-284;

O

  1. Olsen, L D

    1. You have access
      Regiochemistry and substrate stereoselectivity of O-demethylation of verapamil in the presence of the microsomal fraction from rat and human liver.
      W L Nelson, L D Olsen, D B Beitner and R J Pallow
      Drug Metabolism and Disposition March 1988, 16 (2) 184-188;

P

  1. Pallow, R J

    1. You have access
      Regiochemistry and substrate stereoselectivity of O-demethylation of verapamil in the presence of the microsomal fraction from rat and human liver.
      W L Nelson, L D Olsen, D B Beitner and R J Pallow
      Drug Metabolism and Disposition March 1988, 16 (2) 184-188;
  2. Papac, D I

    1. You have access
      N-benzylimidazole, a high magnitude inducer of rat hepatic cytochrome P-450 exhibiting both polycyclic aromatic hydrocarbon- and phenobarbital-type induction of phase I and phase II drug-metabolizing enzymes.
      D I Papac and M R Franklin
      Drug Metabolism and Disposition March 1988, 16 (2) 259-264;
  3. Pfeifer, A

    1. You have access
      Modulation of trans-4-acetylaminostilbene metabolism in the rat by methylcholanthrene and phenobarbital and its relevance for acute toxicity.
      A Pfeifer and H G Neumann
      Drug Metabolism and Disposition March 1988, 16 (2) 276-284;
  4. Pollock, S H

    1. You have access
      Cyclosporine-phenytoin interaction.
      M J D'Souza, S H Pollock and H M Solomon
      Drug Metabolism and Disposition March 1988, 16 (2) 256-258;
  5. Pramanik, B

    1. You have access
      Identification of two metabolites of a penem (Sch 34343) in human urine.
      H Kim, B Pramanik, A Lapiguera, T M Chan, V M Girijavallabhan, S Symchowicz and C Lin
      Drug Metabolism and Disposition March 1988, 16 (2) 325-327;

R

  1. Reynolds, D J

    1. You have access
      The disposition of the hypolipidemic agent, o-(N-phthalimido)acetophenone, in Sprague-Dawley rats.
      I H Hall, D J Reynolds, S D Wyrick, J H Maguire and R P Shrewsbury
      Drug Metabolism and Disposition March 1988, 16 (2) 196-200;

S

  1. Sandy, M S

    1. You have access
      Quantitative analysis of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolism in isolated rat hepatocytes.
      D Di Monte, T Shinka, M S Sandy, N Castagnoli and M T Smith
      Drug Metabolism and Disposition March 1988, 16 (2) 250-255;
  2. Sawada, Y

    1. You have access
      Effect of serum from renal failure and cirrhotic patients on the blood-brain barrier permeability to DL-propranolol in rats.
      T H Lin, Y Sugiyama, Y Sawada, S Kawasaki, T Iga and M Hanano
      Drug Metabolism and Disposition March 1988, 16 (2) 290-295;
    2. You have access
      Efflux of cimetidine from the rat cerebrospinal fluid.
      H Suzuki, Y Sawada, Y Sugiyama, T Iga and M Hanano
      Drug Metabolism and Disposition March 1988, 16 (2) 328-330;
  3. Shinka, T

    1. You have access
      Quantitative analysis of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolism in isolated rat hepatocytes.
      D Di Monte, T Shinka, M S Sandy, N Castagnoli and M T Smith
      Drug Metabolism and Disposition March 1988, 16 (2) 250-255;
  4. Shou, M

    1. You have access
      Regioselective and stereoselective metabolisms of pyrene and 1-bromopyrene by rat liver microsomes and effects of enzyme inducers.
      M Shou and S K Yang
      Drug Metabolism and Disposition March 1988, 16 (2) 173-183;
  5. Shrewsbury, R P

    1. You have access
      The disposition of the hypolipidemic agent, o-(N-phthalimido)acetophenone, in Sprague-Dawley rats.
      I H Hall, D J Reynolds, S D Wyrick, J H Maguire and R P Shrewsbury
      Drug Metabolism and Disposition March 1988, 16 (2) 196-200;
  6. Sieber, M

    1. You have access
      Marked interspecies differences between humans and pigs in cyclosporine and prednisolone disposition.
      B M Frey, M Sieber, D Mettler, H Gänger and F J Frey
      Drug Metabolism and Disposition March 1988, 16 (2) 285-289;
  7. Silber, B M

    1. You have access
      Relationship between the pharmacokinetic and pharmacodynamic profile of nilvadipine in the dog.
      W H Wu, B M Henderson, R Lanc, D Garnes, A Yacobi and B M Silber
      Drug Metabolism and Disposition March 1988, 16 (2) 222-227;
  8. Smith, M T

    1. You have access
      Quantitative analysis of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolism in isolated rat hepatocytes.
      D Di Monte, T Shinka, M S Sandy, N Castagnoli and M T Smith
      Drug Metabolism and Disposition March 1988, 16 (2) 250-255;
  9. Solomon, H M

    1. You have access
      Cyclosporine-phenytoin interaction.
      M J D'Souza, S H Pollock and H M Solomon
      Drug Metabolism and Disposition March 1988, 16 (2) 256-258;
  10. Stewart, J R

    1. You have access
      In vivo renal tubular secretion and metabolism of the disulfide of 2,3-dimercaptopropane-1-sulfonate.
      J R Stewart and G L Diamond
      Drug Metabolism and Disposition March 1988, 16 (2) 189-195;
  11. Strolin-Benedetti, M

    1. You have access
      The metabolism and disposition of fenofibrate in rat, guinea pig, and dog.
      A Weil, J Caldwell and M Strolin-Benedetti
      Drug Metabolism and Disposition March 1988, 16 (2) 302-309;
  12. Sugiyama, Y

    1. You have access
      Effect of serum from renal failure and cirrhotic patients on the blood-brain barrier permeability to DL-propranolol in rats.
      T H Lin, Y Sugiyama, Y Sawada, S Kawasaki, T Iga and M Hanano
      Drug Metabolism and Disposition March 1988, 16 (2) 290-295;
    2. You have access
      Efflux of cimetidine from the rat cerebrospinal fluid.
      H Suzuki, Y Sawada, Y Sugiyama, T Iga and M Hanano
      Drug Metabolism and Disposition March 1988, 16 (2) 328-330;
  13. Suzuki, H

    1. You have access
      Efflux of cimetidine from the rat cerebrospinal fluid.
      H Suzuki, Y Sawada, Y Sugiyama, T Iga and M Hanano
      Drug Metabolism and Disposition March 1988, 16 (2) 328-330;
  14. Symchowicz, S

    1. You have access
      Identification of two metabolites of a penem (Sch 34343) in human urine.
      H Kim, B Pramanik, A Lapiguera, T M Chan, V M Girijavallabhan, S Symchowicz and C Lin
      Drug Metabolism and Disposition March 1988, 16 (2) 325-327;

T

  1. Talaat, R E

    1. You have access
      Regioisomeric aromatic dihydroxylation of propranolol. Use of monohydroxylated intermediates for structural assignments of the metabolites formed in vitro.
      R E Talaat and W L Nelson
      Drug Metabolism and Disposition March 1988, 16 (2) 207-211;
    2. You have access
      Regioisomeric aromatic dihydroxylation of propranolol. Synthesis and identification of 4,6- and 4,8-dihydroxypropranolol as metabolites in the rat and in man.
      R E Talaat and W L Nelson
      Drug Metabolism and Disposition March 1988, 16 (2) 212-216;

V

  1. van Lier, R B

    1. You have access
      Metabolism of 7-ethoxyresorufin by phenobarbital or Aroclor 1254 pretreated mice.
      S J Glass and R B van Lier
      Drug Metabolism and Disposition March 1988, 16 (2) 333-334;

W

  1. Weil, A

    1. You have access
      The metabolism and disposition of fenofibrate in rat, guinea pig, and dog.
      A Weil, J Caldwell and M Strolin-Benedetti
      Drug Metabolism and Disposition March 1988, 16 (2) 302-309;
  2. Weller, P E

    1. You have access
      In vitro metabolism and covalent binding among ortho-substituted bromobenzenes of varying hepatotoxicity.
      P E Weller, N Narasimhan, J A Buben and R P Hanzlik
      Drug Metabolism and Disposition March 1988, 16 (2) 232-237;
  3. Wells, D A

    1. You have access
      Disposition and metabolism of double-labeled [3H and 14C] N-methyl-2-pyrrolidinone in the rat.
      D A Wells and G A Digenis
      Drug Metabolism and Disposition March 1988, 16 (2) 243-249;
  4. Wilking, H

    1. You have access
      Pharmacokinetics and tissue distribution of recombinant human tumor necrosis factor-alpha in mice.
      B L Ferraiolo, J A Moore, D Crase, P Gribling, H Wilking and R A Baughman
      Drug Metabolism and Disposition March 1988, 16 (2) 270-275;
  5. Wu, W H

    1. You have access
      Relationship between the pharmacokinetic and pharmacodynamic profile of nilvadipine in the dog.
      W H Wu, B M Henderson, R Lanc, D Garnes, A Yacobi and B M Silber
      Drug Metabolism and Disposition March 1988, 16 (2) 222-227;
  6. Wyrick, S D

    1. You have access
      The disposition of the hypolipidemic agent, o-(N-phthalimido)acetophenone, in Sprague-Dawley rats.
      I H Hall, D J Reynolds, S D Wyrick, J H Maguire and R P Shrewsbury
      Drug Metabolism and Disposition March 1988, 16 (2) 196-200;

Y

  1. Yacobi, A

    1. You have access
      Relationship between the pharmacokinetic and pharmacodynamic profile of nilvadipine in the dog.
      W H Wu, B M Henderson, R Lanc, D Garnes, A Yacobi and B M Silber
      Drug Metabolism and Disposition March 1988, 16 (2) 222-227;
  2. Yang, S K

    1. You have access
      Regioselective and stereoselective metabolisms of pyrene and 1-bromopyrene by rat liver microsomes and effects of enzyme inducers.
      M Shou and S K Yang
      Drug Metabolism and Disposition March 1988, 16 (2) 173-183;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition
Vol. 16, Issue 2
1 Mar 1988
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics